Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

A review in the Canadian Journal of Physiology and Pharmacology examines emerging evidence linking glucagon-like peptide-1 receptor agonists (GLP-1 RAs), the gut microbiome, and obesity treatment ...

A new Cleveland Clinic study of nearly 8,000 patients found that people who stop popular GLP-1 weight-loss drugs often avoid ...

Glucagon-like peptide-1 receptor agonists (GLP-1s) are a class of medication that includes Ozempic®, Wegovy®, and Saxenda®. Some GLP-1s are diabetes drugs, but you can also take a GLP-1 for weight ...

A large study found that people taking GLP-1 drugs like Ozempic for diabetes were less likely to be diagnosed with substance use disorder.

Studies in a new meta-analysis show sex differences in average weight loss, but similar benefits across other sub-groups.

Wegovy pill, the first FDA‑approved oral GLP‑1 for weight loss, is now available via WeightWatchers Med+ from $149 per month ...

A GLP-1-specific menu was created in Washington, D.C., after the co-founder was told about how hard it was to order at ...

Social media influencers and supplement companies have stoked concerns, but experts say the issue is a lot more complicated.

Patients without diabetes treated with GLP-1s for weight loss are remaining on the drugs without gaps, and switching drugs when needed may help sustain persistence.

Ozempic maker's lawsuit, FDA enforcement could curtail sales of less expensive, compounded, versions of popular weight loss drugs.

As the popularity of weight-loss drugs continues to boom, it has opened the door for scammers eager to dupe people into buying fake versions of the medications. The Better Business Bureau has issued a ...